Image shows photos of all speakers and includes information that is available in post.
FontsA A
ContrastA A
Newsletter sign-up
I give permission for BBMRI-ERIC to send me their newsletter and emails about subjects which they think may be of interest to me. I can unsubscribe from all emails at any time. I understand that my information will be processed according to BBMRI-ERIC's privacy notice.

Online Workshop Day 2: Participant engagement in longitudinal population studies/cohorts

Online

Join us for the 2nd session in our 2-session digital workshop in which the strategies of key European cohorts will be presented and discussed, and experiences exchanged. Work conducted to map participant engagement strategies in European cohorts will also be presented. The workshop is jointly organized by BBMRI-ERIC and Biobank Norway.

Free

EUCAN ELSI Webinar: International Data Sharing

Online

BBMRI-ERIC's Head of ELSI Services & Research Michaela Th. Mayrhofer will speak on societal engagment and social aspects of data sharing at this EUCAN event.

Free

IC2PerMed : Launch of the Virtual Round Tables (VRTs) !

Online

Within VRT#3: ELSI – Four letters – do they matter? European and Chinese experts will provide an overview on the European and Chinese perspective/challenges/limitations/future trends/and much more of Biobanking ELSI in connection with PM. In addition, VRT#3 will build on the WP2 achievements (knowledge synthesis on the identification, transferability and scaling up of international standards in PM), ranging from the WGs workshops to the WP2 roadmap.

4th BBMRI.QM Newsroom

Online

“Get insights from the outside” – with our fourth session of consultation hours on quality-related topics in the field of biobanking and biomedical research and development.

BBMRI.QM Newsroom Continues in 2022

Online

“Get insights from the outside” – with our fifth session of consultation hours on quality-related topics in the field of biobanking and biomedical research and development.

Free

Webinar: Advancing Research on Epidemic-Prone Diseases

The ISIDORe consortium has recently launched its first call to support research on SARS-CoV-2 and COVID-19. It provides free of charge access to more than 300 services from ISIDORe’s integrated portfolio of cutting-edge research services dedicated to epidemic-prone disease research. It will follow in coming weeks with a new access call dedicated to the Monkeypox virus. Read more...

ISIDORe Information Webinar

Online

The ISIDORe coordination team is launching the first in a series of webinars to provide information about ISIDORe initiative, its open calls for proposals dedicated to SARS-CoV-2/COVID-19 and Monkeypox virus, and how to apply to services. The first webinar will be held on 12th July 2022, 10:00-11:30 AM CEST. Please register here for the event […]

Ethics of AI in Imaging: Ethical and Societal Implications

Online

Speakers: Melanie Goisauf and Mónica Cano Abadía (BBMRI-ERIC) Artificial Intelligence (AI) applications in medicine are hoped to improve healthcare and to advance health equity. While the technology carries the potential to improve health services, the ethical and societal implications need to be carefully considered to avoid harmful consequences for individuals and groups, especially for the […]

Free

Webinar: Visualizing the Complexity of Sex Determination

Online

Visualizing the Complexity of Sex Determination, with Amanda Montañez A new installment of the "Sex and Gender in Biomedical Research" webinar series, will take place on Wednesday, November 16th, at 15h (CEST). The title of this webinar is  "Visualizing the Complexity of Sex Determination". The speaker, Amanda Montañez, describes her session as follows: At Scientific […]

Free

The website was co-funded within ADOPT BBMRI-ERIC, a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 676550.
We use cookies to analyse the traffic on our websites. All personal data is anonymized and not shared with third parties! Click here for more information.
Accept